Deep Tech Startups

Quantum Boost offers an AI formulation assistant that helps R&D teams develop chemicals and materials, using AI algorithms to speed up formulation, experimental design, and data analysis. It targets product developers working on chemical and materials research.

2 investors

QLM Technology develops a patented single-diode laser lidar system for continuous, low-cost detection and monitoring of methane and other greenhouse gas emissions. It serves industrial sectors including upstream and downstream gas, refining, wastewater, landfills, and farming.

2 investors

QuantX Bio applies a proprietary computational platform to accelerate the discovery and optimization of drug candidates. The company operates in biotech, using computation to support drug discovery.

2 investors

QuantX develops quantum sensing instruments and precision timing systems for defense, space, and critical infrastructure applications where conventional technology fails. Products include ultra-stable frequency oscillators, compact optical atomic clocks, quantum magnetometers, and synchronization systems for GPS-denied and contested environments.

2 investors

Quidient develops Spatial AI technology centered on Generalized Scene Reconstruction (GSR), which lets users capture real objects and scenes with a mobile device to build high-accuracy virtual 3D models. Its technology combines scene reconstruction, scene understanding, and generative spatial AI, serving enterprise clients such as Fortune 500 companies and government agencies.

2 investors

Quintar builds an infrastructure layer for spatial AI, providing a shared spatial foundation that anchors AI agents, devices, and people to the same real-world reference points. Its technology addresses placing AI content on the correct real-world objects in real time, including use cases such as AI glasses.

2 investors

Quip Network is building a worldwide quantum computer with a team of cryptographers, engineers, and operators focused on quantum-resistant cryptography, smart contracts, and distributed systems.

2 investors

Quoherent develops qubits using topological materials that operate at room temperature, aiming to enable portable, mobile quantum computing without extreme cooling. It works in the quantum computing hardware category.

2 investors

Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.

2 investors

QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.

2 investors

QustomDot develops quantum dot synthesis and engineering technology for applications utilizing nanocrystal and ink-based manufacturing processes. The company provides products based on quantum dot surface engineering and inkjet printing capabilities.

2 investors

R-Go Robotics develops perception technology that gives mobile machines location-aware, human-level visual understanding, allowing them to see, interpret, and operate in complex environments.

2 investors

Radiaction Medical develops a plug-and-play radiation protection device for interventional medical staff that reduces scatter radiation at the source, with FDA Class II clearance for use in the United States, European Union, and United Kingdom. The company serves clinical teams managing radiation exposure during vascular and surgical procedures.

2 investors

Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs. The system is designed for use by healthcare providers in clinical settings to support cancer detection, treatment planning, and precision medicine applications.

2 investors

Radiant designs, builds, and operates full-stack AI infrastructure — powered land, data centers, GPU systems, networking, storage, and managed services — delivered under a single contract and control plane. It serves AI and ML teams that need to run large GPU workloads (from thousands to tens of thousands of GPUs) without assembling infrastructure from separate providers.

2 investors

RadioNano Therapeutics develops boron neutron capture therapy (BNCT), an advanced radiotherapy targeting cancer cells. The company is commercializing RN-501, a nanoparticle-enhanced therapeutic drug aimed at improving treatment safety and efficacy for cancer patients.

2 investors

Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.

2 investors

Raft provides software infrastructure for modern military operations and defense applications. The company builds foundational software systems to support command and control, autonomy, and decision-making capabilities in military contexts.

2 investors

Ramona Optics builds parallelized multi-camera array microscope systems for imaging and analyzing small model organisms and cell cultures in multi-well plates. Its products serve research labs studying zebrafish behavior, morphology, and functional biology, as well as cell confluency and organoids.

2 investors

Ranovus provides optical infrastructure platforms that enable hyperscalers and original design manufacturers to move beyond copper interconnect limits by integrating optical engines closer to high-performance silicon in AI clusters. The company addresses system-level constraints in AI cloud infrastructure scaling through near-packaged and co-packaged optics integration.

2 investors

Rapid Novor develops protein sequencing software and methods for antibody analysis, combining bioinformatics and mass spectrometry technology. The company specializes in proteomics services for clients requiring high-throughput antibody sequencing.

2 investors

Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.

2 investors

Ravee Optics develops ultracompact optical communication systems and laser links for small satellites, space, and airborne platforms.

2 investors

Raven builds Raven Prism, a wearable ambient computer designed for technical creatives, with both hardware and software developed in-house. The company focuses on human-computer interaction design, open ecosystems, and user privacy.

2 investors